Histology And Cytology Market Size, Share & Trends Analysis Report By Type Of Examination (Histology, Cytology), By Product, By Application, By Region, And Segment Forecasts, 2021 - 2028

Histology And Cytology Market Size, Share & Trends Analysis Report By Type Of Examination (Histology, Cytology), By Product, By Application, By Region, And Segment Forecasts, 2021 - 2028

Histology And Cytology Market Growth & Trends

The global histology and cytology market size is expected to reach USD 37.10 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 14.74% from 2021 to 2028. The factors contributing to the market growth include an increase in the demand for the early detection of diseases, increased standardization of pathology laboratories, and implementation of immunohistochemistry and innovation in microscopy.

In addition, organizations are collaborating for the standardization of cytopathology across the world, which is driving the market. For instance, in May 2020, the International Agency for Research on Cancer (IARC)entered in collaboration with the International Academy of Cytology (IAC) for publishing a series of cytopathology reporting systems for presenting an international approach that can be used for cytopathology of different body sites. The two organizations are engaged in the expansion and development of internationally recognized diagnostic reports for cancer and other precancerous disorders worldwide.

Moreover, companies are launching new and automated instruments for cytology, which is further contributing to the market growth. For instance, in January 2021, F. Hoffmann-La Roche Ltd. launched uPath HER2 Dual ISH image analysis and uPath HER2 (4B5) image analysis—two automated digital pathology algorithms for breast cancer. These two solutions offer rapid and accurate patient diagnoses in breast cancer.

COVID-19 has become a catalyst for changing traditional pathology workflows with the integration of artificial intelligence (AI) and digitalization solutions. During the pandemic, these tools have helped and continue to assist in remote reviewing of pathological cases, hence preventing the delay in patient care. Companies have reported the increasing adoption of digital pathology solutionspost-COVID-19.

Histology And Cytology Market Report Highlights

  • Based on type of examination, cytology accounted for the largest revenue share in 2020 and is expected to maintain its lead in the forecast period owing to the integration of computational analytical tools for advancing cytology systems. Histology is expected to witness gradual growth from2021 to 2028 owing to moderate innovation in histological systems
  • In the cytology segment, by application, the other cancers segment held the largest share in 2020 owing to the increasing diagnosis of various cancers such as pancreatic cancer and bile duct cancer with histopathology and cytopathology. The cervical cancer segment is expected to witness the fastest growth over the forecast period. Institutes are integrating computer algorithms for improving the accuracy and efficiency of cervical cancer screening
  • The breast cancer segment held the second-largest share in 2020 owing to the increasing incidence and mortality rates across the globe. This has resulted in the increasing need for the early diagnosis of breast cancer, in turn, driving the segment
  • By product, the consumable and reagents segment dominated the market in 2020 owing to the expanding portfolios of the entities operating in the consumable market space. Instruments and analysis software system is expected to expand at a substantial CAGR from 2021 to 2028 owing to the steep increase in the demand for automated histology instruments
  • In terms of application, the drug discovery and designing segment accounted for the largest revenue share in 2020 owing to the growing importance of cytopathology in disease understanding, further aimed at rapid drug development
  • North America dominated the market in 2020 owing to the prevalence of cancer, the presence of key players, and developed healthcare infrastructure
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1 Methodology And Scope
1.1 Research Assumptions
1.2 Research Methodology
1.3 Information Procurement
1.4 Information or Data Analysis
1.5 Market Formulation & Validation
1.6 Market Model
1.7 Global Market: CAGR Calculation
1.8 Objectives
1.8.1 OBJECTIVE 1:
1.8.2 OBJECTIVE 2:
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
2.4 Market Summary
Chapter 3 Market Variables, Trends, And Scope
3.1 Market Trends and Outlook
3.2 Market Lineage Outlook
3.3 Parent Market Outlook
3.4 Market Segmentation and Scope
3.5 Market Dynamics
3.5.1 Market Driver Analysis
3.5.1.1 Rising incidence of cancer
3.5.1.2 Technological developments
3.5.1.3 Increase in awareness programs for cervical cancer screening
3.5.2 Market Restraint Analysis
3.5.2.1 Low sensitivity of cytology tests
3.5.2.2 Conditions required for specimens and problem of mislabeled specimens
3.6 Penetration and Growth Prospect Mapping for Products, 2020 (USD Million)
3.7 Business Environment Analysis
3.7.1 SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.7.1.1 Political & Legal
3.7.1.1.1 Strengths
3.7.1.1.2 Weaknesses
3.7.1.1.3 Opportunities
3.7.1.1.4 Threats
3.7.1.2 Economic
3.7.1.2.1 Strengths
3.7.1.2.2 Weaknesses
3.7.1.2.3 Opportunities
3.7.1.2.4 Threats
3.7.1.3 Technological
3.7.1.3.1 Strengths
3.7.1.3.2 Weaknesses
3.7.1.3.3 Opportunities
3.7.1.3.4 Threats
3.7.2 Porter’s Five Forces Analysis
3.8 Regulatory Framework
3.8.1 U.K.
3.8.2 U.S.
3.8.2.1 CLIA Law-October 31, 1988
3.8.2.2 CLIA Law-October February 28, 1992
3.9 Reimbursement Scenario
3.10 Research Institutes: Histology and Cytology Market
3.11 Major Deals & Strategic Alliances Analysis
3.11.1 Joint Ventures
3.11.2 Licensing & Partnership
3.11.3 Mergers & Acquisitions
3.11.4 Technology Collaborations
3.12 Market Entry Strategies
3.13 Impact of COVID-19 Pandemic on Market Growth
Chapter 4 Histology And Cytology Market Categorization: Type Of Examination Estimates & Trend Analysis
4.1 Histology and Cytology Market: Type of Examination Movement Analysis
4.2 Histology
4.2.1 Global Histology Market, 2017 - 2028 (USD Million)
4.2.2 By Technique
4.2.2.1 Microscopy
4.2.2.1.1 Global histology market by microscopy, 2017 - 2028 (USD Million)
4.2.2.2 Immunohistochemistry
4.2.2.2.1 Global histology market by immunohistochemistry, 2017 - 2028 (USD Million)
4.2.2.3 Molecular Pathology
4.2.2.3.1 Global histology market by molecular pathology, 2017 - 2028 (USD Million)
4.2.2.4 Cryostat & Microtomy
4.2.2.4.1 Global histology market by cryostat & microtomy, 2017 - 2028 (USD Million)
4.3 Cytology
4.3.1 Global Cytology Market, 2017 - 2028 (USD Million)
4.3.2 By Technique
4.3.2.1 Microscopy
4.3.2.1.1 Global cytology market by microscopy, 2017 - 2028 (USD Million)
4.3.2.2 Immunohistochemistry
4.3.2.2.1 Global cytology market by immunohistochemistry, 2017 - 2028 (USD Million)
4.3.2.3 Molecular Pathology
4.3.2.3.1 Global cytology market by molecular pathology, 2017 - 2028 (USD Million)
4.3.2.4 Cryostat & Microtomy
4.3.2.4.1 Global cytology market by cryostat & microtomy, 2017 - 2028 (USD Million)
4.3.3 By Application
4.3.3.1 Cervical cancer
4.3.3.1.1 Global cervical cancer cytology market, 2017 - 2028 (USD Million)
4.3.3.2 Breast cancer
4.3.3.2.1 Global breast cancer cytology market, 2017 - 2028 (USD Million)
4.3.3.3 Bladder cancer
4.3.3.3.1 Global bladder cancer cytology market, 2017 - 2028 (USD Million)
4.3.3.4 Lung cancer
4.3.3.4.1 Global lung cancer cytology market, 2017 - 2028 (USD Million)
4.3.3.5 Other cancer
4.3.3.5.1 Pancreatic cancer
4.3.3.5.2 Bile duct
4.3.3.5.3 Global other cancers cytology market, 2017 - 2028 (USD Million)
Chapter 5 Histology And Cytology Market Categorization: Product Estimates And Trend Analysis
5.1 Histology and Cytology Market: Product Movement Analysis
5.2 Instruments and Analysis Software System
5.2.1 Global Histology And Cytology Instruments & Analysis Software System Market, 2017 - 2028 (USD Million)
5.3 Consumable and Reagents
5.3.1 Global Histology And Cytology Consumable & Reagents Market, 2017 - 2028 (USD Million)
Chapter 6 Histology And Cytology Market Categorization: Application Business Analysis
6.1 Histology and Cytology Market: Application Movement Analysis
6.2 Drug Discovery & Designing
6.2.1 Global Histology And Cytology Market For Drug Discovery & Designing, 2017 - 2028 (USD Million)
6.3 Clinical Diagnostics
6.3.1 Global Histology And Cytology Clinical Diagnostics Market, 2017 - 2028 (USD Million)
6.3.2 Point-of-Care (PoC)
6.3.2.1 Global Histology And Cytology Market For Point-of-Care Diagnostics, 2017 - 2028 (USD Million)
6.3.3 Non-Point-of-Care
6.3.3.1 Global Histology And Cytology Market For Non-Point-of-Care Diagnostics, 2017 - 2028 (USD Million)
6.4 Research
6.4.1 Global Histology And Cytology Market For Research Applications, 2017 - 2028 (USD Million)
Chapter 7 Histology And Cytology Market Regional Business Analysis
7.1 Histology and Cytology Market share by Region, 2020 & 2028
7.2 Market Players, by Region
7.3 SWOT Analysis, by Region
7.4 North America
7.4.1 North America Histology And Cytology Market Estimates And Forecast, 2017 - 2028 (USD Million)
7.4.2 U.S.
7.4.2.1 U.S. histology and cytology market by type of examination, 2017 - 2028 (USD Million)
7.4.2.2 U.S. histology market, by technique, 2017 - 2028 (USD Million)
7.4.2.3 U.S. cytology market, by technique, 2017 - 2028 (USD Million)
7.4.2.4 U.S. cytology market, by application, 2017 - 2028 (USD Million)
7.4.2.5 U.S. histology and cytology market, by product, 2017 - 2028 (USD Million)
7.4.2.6 U.S. histology and cytology market, by application, 2017 - 2028 (USD Million)
7.4.2.7 U.S. histology and cytology market for clinical diagnostics, by application, 2017 - 2028 (USD Million)
7.4.3 Canada
7.4.3.1 Canada histology and cytology market by type of examination, 2017 - 2028 (USD Million)
7.4.3.2 Canada histology market, by technique, 2017 - 2028 (USD Million)
7.4.3.3 Canada cytology market, by technique, 2017 - 2028 (USD Million)
7.4.3.4 Canada cytology market, by application, 2017 - 2028 (USD Million)
7.4.3..5 Canada histology and cytology market, by product, 2017 - 2028 (USD Million)
7.4.3.6 Canada histology and cytology market, by application, 2017 - 2028 (USD Million)
7.4.3.7 Canada histology and cytology market for clinical diagnostics, by application, 2017 - 2028 (USD Million)
7.5 Europe
7.5.1 Europe Histology And Cytology Market Estimates And Forecast, 2017-2028 (USD Million)
7.5.2 Germany
7.5.2.1 Germany histology and cytology market by type of examination, 2017 - 2028 (USD Million)
7.5.2.2 Germany histology market, by technique, 2017 - 2028 (USD Million)
7.5.2.3 Germany cytology market, by technique, 2017 - 2028 (USD Million)
7.5.2.4 Germany cytology market, by application, 2017 - 2028 (USD Million)
7.5.2.5 Germany histology and cytology market, by product, 2017 - 2028 (USD Million)
7.5.2.6 Germany histology and cytology market, by application, 2017 - 2028 (USD Million)
7.5.2.7 Germany histology and cytology market for clinical diagnostics, by application, 2017 - 2028 (USD Million)
7.5.3 U.K.
7.5.3.1 U.K. histology and cytology market by type of examination, 2017 - 2028 (USD Million)
7.5.3.2 U.K. histology market, by technique, 2017 - 2028 (USD Million)
7.5.3.3 U.K. cytology market, by technique, 2017 - 2028 (USD Million)
7.5.3.4 U.K. cytology market, by application, 2017 - 2028 (USD Million)
7.5.3.5 U.K. histology and cytology market, by product, 2017 - 2028 (USD Million)
7.5.3.6 U.K. histology and cytology market, by application, 2017 - 2028 (USD Million)
7.5.3.7 U.K. histology and cytology market for clinical diagnostics, by application, 2017 - 2028 (USD Million)
7.5.4 France
7.5.4.1 France histology and cytology market by type of examination, 2017 - 2028 (USD Million)
7.5.4.2 France histology market, by technique, 2017 - 2028 (USD Million)
7.5.4.3 France cytology market, by technique, 2017 - 2028 (USD Million)
7.5.4.4 France cytology market, by application, 2017 - 2028 (USD Million)
7.5.4.5 France histology and cytology market, by product, 2017 - 2028 (USD Million)
7.5.4.6 France histology and cytology market, by application, 2017 - 2028 (USD Million)
7.5.4.7 France histology and cytology market for clinical diagnostics, by application, 2017 - 2028 (USD Million)
7.5.5 Italy
7.5.5.1 Italy histology and cytology market by type of examination, 2017 - 2028 (USD Million)
7.5.5.2 Italy histology market, by technique, 2017 - 2028 (USD Million)
7.5.5.3 Italy cytology market, by technique, 2017 - 2028 (USD Million)
7.5.5.4 Italy cytology market, by application, 2017 - 2028 (USD Million)
7.5.5.5 Italy histology and cytology market, by product, 2017 - 2028 (USD Million)
7.5.5.6 Italy histology and cytology market, by application, 2017 - 2028 (USD Million)
7.5.5.7 Italy histology and cytology market for clinical diagnostics, by application, 2017 - 2028 (USD Million)
7.5.6 Spain
7.5.6.1 Spain histology and cytology market by type of examination, 2017 - 2028 (USD Million)
7.5.6.2 Spain histology market, by technique, 2017 - 2028 (USD Million)
7.5.6.3 Spain cytology market, by technique, 2017 - 2028 (USD Million)
7.5.6.4 Spain cytology market, by application, 2017 - 2028 (USD Million)
7.5.6.5 Spain histology and cytology market, by product, 2017 - 2028 (USD Million)
7.5.6.6 Spain histology and cytology market, by application, 2017 - 2028 (USD Million)
7.5.6.7 Spain histology and cytology market for clinical diagnostics, by application, 2017 - 2028 (USD Million)
7.6 Asia Pacific
7.6.1 Asia Pacific Histology And Cytology Market Estimates And Forecast, 2017-2028 (USD Million)
7.6.2 Japan
7.6.2.1 Japan histology and cytology market by type of examination, 2017 - 2028 (USD Million)
7.6.2.2 Japan histology market, by technique, 2017 - 2028 (USD Million)
7.6.2.3 Japan cytology market, by technique, 2017 - 2028 (USD Million)
7.6.2.4 Japan cytology market, by application, 2017 - 2028 (USD Million)
7.6.2..5 Japan histology and cytology market, by product, 2017 - 2028 (USD Million)
7.6.2..6 Japan histology and cytology market, by application, 2017 - 2028 (USD Million)
7.6.2.7 Japan histology and cytology market for clinical diagnostics, by application, 2017 - 2028 (USD Million)
7.6.3 China
7.6.3.1 China histology and cytology market by type of examination, 2017 - 2028 (USD Million)
7.6.3.2 China histology market, by technique, 2017 - 2028 (USD Million)
7.6.3.3 China cytology market, by technique, 2017 - 2028 (USD Million)
7.6.3.4 China cytology market, by application, 2017 - 2028 (USD Million)
7.6.3..5 China histology and cytology market, by product, 2017 - 2028 (USD Million)
7.6.3..6 China histology and cytology market, by application, 2017 - 2028 (USD Million)
7.6.3.7 China histology and cytology market for clinical diagnostics, by application, 2017 - 2028 (USD Million)
7.6.4 India
7.6.4.1 India histology and cytology market by type of examination, 2017 - 2028 (USD Million)
7.6.4.2 India histology market, by technique, 2017 - 2028 (USD Million)
7.6.4.3 India cytology market, by technique, 2017 - 2028 (USD Million)
7.6.4.4 India cytology market, by application, 2017 - 2028 (USD Million)
7.6.4..5 India histology and cytology market, by product, 2017 - 2028 (USD Million)
7.6.4..6 India histology and cytology market, by application, 2017 - 2028 (USD Million)
7.6.4.7 India histology and cytology market for clinical diagnostics, by application, 2017 - 2028 (USD Million)
7.7 Latin America
7.7.1 Latin America Histology And Cytology Market Estimates And Forecast, 2017-2028 (USD Million)
7.7.2 Brazil
7.7.2.1 Brazil histology and cytology market by type of examination, 2017 - 2028 (USD Million)
7.7.2.2 Brazil histology market, by technique, 2017 - 2028 (USD Million)
7.7.2.3 Brazil cytology market, by technique, 2017 - 2028 (USD Million)
7.7.2.4 Brazil cytology market, by application, 2017 - 2028 (USD Million)
7.7.2.5 Brazil histology and cytology market, by product, 2017 - 2028 (USD Million)
7.7.2..6 Brazil histology and cytology market, by application, 2017 - 2028 (USD Million)
7.7.2.7 Brazil histology and cytology market for clinical diagnostics, by application, 2017 - 2028 (USD Million)
7.7.3 Mexico
7.7.3.1 Mexico histology and cytology market by type of examination, 2017 - 2028 (USD Million)
7.7.3.2 Mexico histology market, by technique, 2017 - 2028 (USD Million)
7.7.3.3 Mexico cytology market, by technique, 2017 - 2028 (USD Million)
7.7.3.4 Mexico cytology market, by application, 2017 - 2028 (USD Million)
7.7.3.5 Mexico histology and cytology market, by product, 2017 - 2028 (USD Million)
7.7.3.6 Mexico histology and cytology market, by application, 2017 - 2028 (USD Million)
7.7.3.7 Mexico histology and cytology market for clinical diagnostics, by application, 2017 - 2028 (USD Million)
7.8 Middle East and Africa (MEA)
7.8.1 MEA Histology And Cytology Market Estimates And Forecast, 2017-2028 (USD Million)
7.8.2 South Africa
7.8.2.1 South Africa histology and cytology market by type of examination, 2017 - 2028 (USD Million)
7.8.2.2 South Africa histology market, by technique, 2017 - 2028 (USD Million)
7.8.2.3 South Africa cytology market, by technique, 2017 - 2028 (USD Million)
7.8.2.4 South Africa cytology market, by application, 2017 - 2028 (USD Million)
7.8.2.5 South Africa histology and cytology market, by product, 2017 - 2028 (USD Million)
7.8.2.6 South Africa histology and cytology market, by application, 2017 - 2028 (USD Million)
7.8.2.7 South Africa histology and cytology market for clinical diagnostics, by application, 2017 - 2028 (USD Million)
Chapter 8 Company Profile
8.1 Strategy Framework
8.2 Market Participation Categorization
8.3 Company Profiles
8.3.1 Hologic, Inc.
8.3.1.1 Company Overview
8.3.1.2 Financial Performance
8.3.1.3 Product Benchmarking
8.3.1.4 Strategic Initiatives
8.3.2 F. Hoffmann-La Roche Ltd.
8.3.2.1 Company Overview
8.3.2.2 Financial Performance
8.3.2.3 Product Benchmarking
8.3.2.4 Strategic Initiatives
8.3.3 Abbott
8.3.3.1 Company Overview
8.3.3.2 Alere
8.3.3.3 Financial Performance
8.3.3.4 Product Benchmarking
8.3.3.5 Strategic Initiatives
8.3.3.6 Strategic Initiatives (Alere)
8.3.4 Becton, Dickinson & Company
8.3.4.1 Company Overview
8.3.4.2 Financial Performance
8.3.4.3 Product Benchmarking
8.3.4.4 Strategic Initiatives
8.3.5 Danaher Corporation
8.3.5.1 Company Overview
8.3.5.2 Leica Biosystems Nussloch Gmbh
8.3.5.3 Financial Performance
8.3.5.4 Financial Performance (Leica Biosystems Nussloch Gmbh)
8.3.5.5 Product Benchmarking
8.3.5.6 Strategic Initiatives
8.3.6 Merck KGaA
8.3.6.1 Company Overview
8.3.6.2 Sigma-Aldrich Co. LLC
8.3.6.3 Financial Performance
8.3.6.4 Product Benchmarking
8.3.6.5 Strategic Initiatives
8.3.7 Thermo Fisher Scientific, Inc.
8.3.7.1 Company Overview
8.3.7.2 Financial Performance
8.3.7.3 Product Benchmarking
8.3.7.4 Strategic Initiatives
8.3.8 Sysmex Corporation
8.3.8.1 Company Overview
8.3.8.2 Financial Performance
8.3.8.3 Product Benchmarking
8.3.8.4 Strategic Initiatives
8.3.9 Trivitron Healthcare
8.3.9.1 Company Overview
8.3.9.2 Financial Performance
8.3.9.3 Product Benchmarking
8.3.9.4 Strategic Initiatives
8.3.10 Koninklijke Philips N.V.
8.3.10.1 Company Overview
8.3.10.2 Financial Performance
8.3.10.3 Product Benchmarking
8.3.10.4 Strategic Initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook